Systemic lupus erythematosus.
D000974:Antibodies, Antinuclear; D001172:Arthritis, Rheumatoid / Q000175:diagnosis; D005260:Female; D006505:Hepatitis / Q000150:complications; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D007136:Immunoglobulins; D007668:Kidney / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D008297:Male; D009393:Nephritis / Q000209:etiology; D009504:Neutrophils; D011241:Prednisone / Q000627:therapeutic use; D011342:Procainamide / Q000009:adverse effects; D011379:Prognosis; D012867:Skin / Q000473:pathology
D000974:Antibodies, Antinuclear; D007136:Immunoglobulins; D006830:Hydralazine; D011342:Procainamide; D011241:Prednisone